A 62-year-old with newly diagnosed HFrEF (LVEF 30%) is euvolemic after diuresis. Which set of disease-modifying agents should be targeted early for long-term mortality reduction?ALoop diuretic, digoxin, ivabradine, nitratesBACE inhibitor or ARNI, evidence-based beta-blocker, mineralocorticoid receptor antagonist, SGLT2 inhibitorCHydralazine-isosorbide dinitrate, amiodarone, loop diuretic, verapamilDNon-DHP calcium channel blocker, ACE inhibitor, loop diuretic, statinESGLT2 inhibitor monotherapyCheck my answer